Zosano Pharma Corp. Daily Stock Analysis

Daily Stock Analysis, ZSAN, Zosano Pharma Corp, priceseries

Zosano Pharma Corp. Daily Stock Analysis
Stock Information
Open
0.17
Close
0.16
High
0.17
Low
0.16
Previous Close
0.17
Daily Price Gain
-0.01
YTD High
0.71
YTD High Date
Jan 5, 2022
YTD Low
0.11
YTD Low Date
Feb 24, 2022
YTD Price Change
-0.37
YTD Gain
-70.43%
52 Week High
1.52
52 Week High Date
Mar 17, 2021
52 Week Low
0.11
52 Week Low Date
Feb 24, 2022
52 Week Price Change
-1.03
52 Week Gain
-86.83%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 4. 2017
17.40
Jan 26. 2017
22.45
15 Trading Days
29.01%
Link
LONG
Feb 14. 2017
40.40
Feb 23. 2017
45.90
6 Trading Days
13.61%
Link
LONG
Mar 6. 2018
9.28
Mar 23. 2018
16.08
13 Trading Days
73.31%
Link
LONG
Jul 30. 2020
0.95
Aug 12. 2020
1.28
9 Trading Days
34.73%
Link
LONG
Aug 13. 2020
1.36
Aug 27. 2020
1.65
10 Trading Days
21.36%
Link
LONG
Feb 3. 2021
1.02
Feb 17. 2021
1.53
9 Trading Days
50.29%
Link
Company Information
Stock Symbol
ZSAN
Exchange
NasdaqCM
Company URL
http://www.zosanopharma.com
Company Phone
510-745-1200
CEO
Konstantinos Alataris
Headquarters
California
Business Address
34790 ARDENTECH COURT, FREMONT, CA 94555
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001587221
About

Zosano Pharma Corp. is a clinical stage pharmaceutical company that develops proprietary intracutaneous delivery system. It offers rapid absorption of drug, consistent drug delivery, improved ease of use and room-temperature stability, benefits that differentiate its delivery platform from other non-oral formulations or injections. The company was founded in January 2012 and is headquartered in Fremont, CA.

Description

Zosano Pharma Corporation, a clinical stage pharmaceutical company, develops a proprietary intracutaneous delivery system to administer drugs through the skin for rapid symptom relief to patients. Its lead product candidate is M207, a proprietary formulation of zolmitriptan used for the treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading